A survey of physician experience and treatment satisfaction prescribing once-weekly semaglutide injections for patients with type 2 diabetes in Canada

por Qureshy, Kamran, Ross Kirk, Andreas, Lyng Wolden, Michael, Abbas Mohseni Zonoozi, Amir, Liu, Aiden
Publicado 2022

Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting

por Stafford, Sara, Bech, Peter G., Fridhammar, Adam, Miresashvili, Nino, Nilsson, Andreas, Willis, Michael, Liu, Aiden
Publicado 2022

Correction to: Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting

por Stafford, Sara, Bech, Peter G., Fridhammar, Adam, Miresashvili, Nino, Nilsson, Andreas, Willis, Michael, Liu, Aiden
Publicado 2022

Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada

por Johansen, Pierre, Håkan-Bloch, Jonas, Liu, Aiden R., Bech, Peter G., Persson, Sofie, Leiter, Lawrence A.
Publicado 2019

Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study

por Cheng, Alice Y.Y., Goldenberg, Ronald, Krawchenko, Iris, Tytus, Richard, Hahn, Jina, Liu, Aiden, Golden, Shane, Millson, Brad, Harris, Stewart
Publicado 2023

Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional Study

por Cheng, Alice Y.Y., Harris, Stewart, Krawchenko, Iris, Tytus, Richard, Hahn, Jina, Liu, Aiden, Millson, Brad, Golden, Shane, Goldenberg, Ronald
Publicado 2023

Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program

por Wharton, Sean, Haase, Christiane L, Kamran, Elham, Liu, Aiden, Mancini, Johanna, Neish, Drew, Pakseresht, Arash, Power, G Sarah, Christensen, Rebecca AG
Publicado 2020

A matched case-control study to assess the association between non-steroidal anti-inflammatory drug use and thrombotic microangiopathy

por Liu, Aiden R., Hildebrand, Ainslie M., Dixon, Stephanie, Sontrop, Jessica M., Clark, William F., Lazo-Langner, Alejandro, Nash, Danielle, Garg, Amit X.
Publicado 2018

Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada

por Wharton, Sean, Liu, Aiden, Pakseresht, Arash, Nørtoft, Emil, Haase, Christiane L., Mancini, Johanna, Power, G. Sarah, Vanderlelie, Sarah, Christensen, Rebecca A. G.
Publicado 2019

Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada

por Wharton, Sean, Haase, Christiane L., Kamran, Elham, Liu, Aiden, Mancini, Johanna, Neish, Drew, Pakseresht, Arash, Power, G Sarah, Christensen, Rebecca A. G.
Publicado 2020

Perceptions of barriers to effective obesity management in Canada: Results from the ACTION study

por Sharma, Arya M., Bélanger, André, Carson, Veronica, Krah, Jodi, Langlois, Marie‐France, Lawlor, Diana, Lepage, Suzanne, Liu, Aiden, Macklin, David A., MacKay, Noel, Pakseresht, Arash, Pedersen, Sue D., Ramos Salas, Ximena, Vallis, Michael
Publicado 2019